Eflapegrastim (Rolvedon) for Prevention of Chemotherapy-Induced Febrile Neutropenia

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2023年 / 65卷 / 1677期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Eflapegrastim-xnst (Rolvedon [Spectrum]; previously called Rolontis), a granulocyte colony-stimulating factor (G-CSF) conjugated to an Fc fragment of human IgG4, has been approved by the FDA to decrease the incidence of infection, as manifested by febrile neutropenia, in adults with nonmyeloid malignancies receiving myelosuppressive chemotherapy that can cause clinically significant febrile neutropenia.
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [31] Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review
    Blayney, Douglas W.
    Schwartzberg, Lee
    CANCER TREATMENT REVIEWS, 2022, 109
  • [32] Prevention of Chemotherapy-Induced Neutropenia with Pegfilgrastim: Pharmacokinetics and Patient Outcomes
    Yang, Bing-Bing
    Savin, Michael A.
    Green, Michael
    CHEMOTHERAPY, 2012, 58 (05) : 387 - 398
  • [33] Chemotherapy adjuvant and chemotherapy-induced neutropenia
    Li, Yiu-Tai
    Yang, Szu-Ting
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2022, 61 (04): : 573 - 574
  • [34] Lenograstim in Preventing Chemotherapy-induced Febrile Neutropenia in Patients with Soft Tissue Sarcoma
    Badalamenti, Giuseppe
    Incorvaia, Lorena
    Provenzano, Salvatore
    Bronte, Giuseppe
    Leto, Gaetano
    Fulfaro, Fabio
    Maltese, Giuseppa
    ANTICANCER RESEARCH, 2013, 33 (02) : 679 - 684
  • [35] Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia
    Otremba, Burkhard
    Hielscher, Carsten
    Petersen, Volker
    Petrik, Christian
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 2179 - 2186
  • [36] Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia
    Shin Ahn
    Yoon-Seon Lee
    Yun-Hee Chun
    In-Ho Kwon
    Won Kim
    Kyung Soo Lim
    Tae Won Kim
    Kyoo-Hyung Lee
    Supportive Care in Cancer, 2011, 19 : 1151 - 1158
  • [37] Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors
    Weycker, Derek
    Li, Xiaoyan
    Edelsberg, John
    Barron, Rich
    Kartashov, Alex
    Xu, Hairong
    Lyman, Gary H.
    JOURNAL OF ONCOLOGY PRACTICE, 2015, 11 (01) : 47 - +
  • [38] Optimal dose of amikacin in childhood chemotherapy-induced febrile neutropenia: Beware of underdosing
    Lesieur, T.
    Goyer, I.
    Bourgine, J.
    Bodet, D.
    Cesbron, A.
    Deparis, M.
    Loilier, M.
    Rouger, J.
    Lelong-Boulouard, V.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 179 - 180
  • [39] INVASIVE FUNGAL INFECTION AMONG FEBRILE PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA IN THAILAND
    Phikulsod, Ployploen
    Suwannawiboon, Bundarika
    Chayakulkeeree, Methee
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2017, 48 (01) : 159 - 169
  • [40] Lecture: management of chemotherapy-induced febrile neutropenia; guidelines and colony stimulating factors
    Procopio, Giuseppe
    Niger, Monica
    Testa, Isabella
    NEUROLOGICAL SCIENCES, 2011, 32 : S217 - S219
12345